Pharmacotherapeutics for
Advanced Practice Nurse
Prescribers with Davis Edge
6th Edition
• Author(s)Teri Moser Woo; Wendy
L. Wright
TEST BANK
▪ The Foundation
▪ Pharmacotherapeutics with Single Drugs
▪ Pharmacotherapeutics with Multiple Drugs
▪ Special Drug Treatment Considerations
,B. Current pregnancy status and reproductive plans
C. Number of previous primary care visits
D. Employment schedule
Correct Answer: B
Rationale:
Many medications have teratogenic potential or require dose
modifications during pregnancy. Assessing pregnancy status,
contraceptive use, and reproductive intentions is an essential
component of safe prescribing for patients of reproductive potential.
This assessment supports informed decision-making and reduces fetal
medication exposure risks.
• A: Pharmacy preference affects convenience but not prescribing
safety.
• C: Visit history has minimal impact on medication selection.
• D: Work schedule may influence adherence but is secondary to
assessing pregnancy-related safety.
Question 4
An APRN is initiating long-term pharmacotherapy for newly diagnosed
type 2 diabetes. Which follow-up plan best reflects safe prescribing
principles?
A. Reevaluate the patient only if symptoms worsen.
B. Schedule routine follow-up to assess medication effectiveness,
adverse effects, adherence, and laboratory monitoring.
,C. Continue therapy indefinitely without reassessment if the initial
prescription is tolerated.
D. Repeat laboratory studies only when requested by the patient.
Correct Answer: B
Rationale:
Safe prescribing requires ongoing monitoring after initiating therapy.
Follow-up should include evaluation of therapeutic response,
medication adherence, adverse effects, laboratory monitoring when
indicated, and dose adjustments based on clinical outcomes.
Continuous reassessment improves medication safety and
effectiveness.
• A: Waiting for symptoms may delay recognition of treatment
failure or toxicity.
• C: Long-term therapy requires periodic reassessment.
• D: Laboratory monitoring should follow evidence-based
recommendations rather than patient request alone.
Question 5
A newly certified APRN is reviewing a patient's complete medication list
before prescribing a new antihypertensive medication. Which
prescribing practice most effectively reduces medication-related harm?
A. Focus only on prescription medications documented in the electronic
health record.
B. Ask specifically about prescription drugs, over-the-counter
medications, herbal supplements, vitamins, and dietary products.
, C. Assume patients will disclose important medications if interactions
occur.
D. Delay medication reconciliation until the follow-up visit.
Correct Answer: B
Rationale:
Comprehensive medication reconciliation is a cornerstone of safe
prescribing. Many clinically significant drug interactions involve over-
the-counter medications, herbal products, supplements, and vitamins.
Obtaining a complete medication history helps identify duplicative
therapy, contraindications, interactions, allergies, and opportunities to
simplify medication regimens.
• A: Overlooking nonprescription products increases the risk of
harmful interactions.
• C: Patients often do not recognize supplements or OTC
medications as important to report.
• D: Medication reconciliation should occur before prescribing to
prevent avoidable adverse drug events.
Question 6
A nurse practitioner is preparing to prescribe a newly approved
medication for a patient with chronic heart failure. Before initiating
therapy, which action best reflects evidence-based prescribing?
Advanced Practice Nurse
Prescribers with Davis Edge
6th Edition
• Author(s)Teri Moser Woo; Wendy
L. Wright
TEST BANK
▪ The Foundation
▪ Pharmacotherapeutics with Single Drugs
▪ Pharmacotherapeutics with Multiple Drugs
▪ Special Drug Treatment Considerations
,B. Current pregnancy status and reproductive plans
C. Number of previous primary care visits
D. Employment schedule
Correct Answer: B
Rationale:
Many medications have teratogenic potential or require dose
modifications during pregnancy. Assessing pregnancy status,
contraceptive use, and reproductive intentions is an essential
component of safe prescribing for patients of reproductive potential.
This assessment supports informed decision-making and reduces fetal
medication exposure risks.
• A: Pharmacy preference affects convenience but not prescribing
safety.
• C: Visit history has minimal impact on medication selection.
• D: Work schedule may influence adherence but is secondary to
assessing pregnancy-related safety.
Question 4
An APRN is initiating long-term pharmacotherapy for newly diagnosed
type 2 diabetes. Which follow-up plan best reflects safe prescribing
principles?
A. Reevaluate the patient only if symptoms worsen.
B. Schedule routine follow-up to assess medication effectiveness,
adverse effects, adherence, and laboratory monitoring.
,C. Continue therapy indefinitely without reassessment if the initial
prescription is tolerated.
D. Repeat laboratory studies only when requested by the patient.
Correct Answer: B
Rationale:
Safe prescribing requires ongoing monitoring after initiating therapy.
Follow-up should include evaluation of therapeutic response,
medication adherence, adverse effects, laboratory monitoring when
indicated, and dose adjustments based on clinical outcomes.
Continuous reassessment improves medication safety and
effectiveness.
• A: Waiting for symptoms may delay recognition of treatment
failure or toxicity.
• C: Long-term therapy requires periodic reassessment.
• D: Laboratory monitoring should follow evidence-based
recommendations rather than patient request alone.
Question 5
A newly certified APRN is reviewing a patient's complete medication list
before prescribing a new antihypertensive medication. Which
prescribing practice most effectively reduces medication-related harm?
A. Focus only on prescription medications documented in the electronic
health record.
B. Ask specifically about prescription drugs, over-the-counter
medications, herbal supplements, vitamins, and dietary products.
, C. Assume patients will disclose important medications if interactions
occur.
D. Delay medication reconciliation until the follow-up visit.
Correct Answer: B
Rationale:
Comprehensive medication reconciliation is a cornerstone of safe
prescribing. Many clinically significant drug interactions involve over-
the-counter medications, herbal products, supplements, and vitamins.
Obtaining a complete medication history helps identify duplicative
therapy, contraindications, interactions, allergies, and opportunities to
simplify medication regimens.
• A: Overlooking nonprescription products increases the risk of
harmful interactions.
• C: Patients often do not recognize supplements or OTC
medications as important to report.
• D: Medication reconciliation should occur before prescribing to
prevent avoidable adverse drug events.
Question 6
A nurse practitioner is preparing to prescribe a newly approved
medication for a patient with chronic heart failure. Before initiating
therapy, which action best reflects evidence-based prescribing?
